The Biopharma CEO Confidence Index is a forward-looking indicator designed to measure C-suite sentiment and confidence in the biopharma industry’s economy. Click below to view current and past results.
- 2018 Q3 Results
- 2017 Q2 Results
- 2016 Q3/Q4 Results
- 2016 Q2 Results
- 2016 Q1 Results
- 2015 Q4 Results
- 2015 Q3 Results
This confidence—or lack thereof—is defined by the degree of optimism within key business indicators. Measuring confidence through these six indicators over time will demonstrate an ebb and flow of market dynamics and confidence in the future success of companies and growth in the overall market.
- Capital Markets
- Deal Landscape
- Clinical Development
- Regulatory Affairs
- Commercialization
- Business Model and Workforce